19/05/2018 7o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | Michael Reardon - 7th Conference of Transcatheter Heart Valve Therapies

info_icon

 

Δηλώνω υπεύθυνα ότι είμαι γιατρός ή εξασκώ παραϊατρικό επάγγελμα |

I hereby declare that I am medical professional 

 

Συμφωνώ | Άκυρο

416 VIEWS EXPANDCOLLAPSE

Share

74,213 total
405 live
416 video
26,446 photo
Views:

Michael Reardon - Professor of Cardiothoracic Surgery, Allison Family Distinguished Chair of Cardiovascular - 7th Conference of Transcatheter Heart Valve Therapies #lmn #mednews

 
Sort by Date | Views

Παρακολουθήστε ζωντανά και αποθηκευμένα το 7o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών  που διοργανώνει το Διαγνωστικό Θεραπευτήριο Κέντρο Αθηνών Υγεία στις 18-19 Μαίου 2018 στο ξενοδοχείο Hilton στην Αθήνα.  

 

Για περισσότερες πληροφορίες πατήστε εδώ.

7o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών... 595
7ο Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών... 476
7ο Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών... 371
J.Iakovou | Management of stable and unstable... 450
G.Trantalis | Predilatation and postdilation... 410
A.Manginas | Emergent TAVR in AS patients... 426
A.Chalapas | TAVR in patients with end-stage... 476
K.Spargias | How Do I Manage These Challenging... 433
G.Pattakos | Will the Heart Team Survive... 426
G.Katsimagklis | My best and worst TAVR... 437
G.Karavolias | My best and worst TAVR case... 385
V.Tzifos | My best and worst TAVR case of... 436
G.Sianos | My best and worst TAVR case of... 395
S.Pattakos | 421
G.Zacharopoulos | 463
K.Tsioufis | 510
D.Tousoulis | 506
P.Vardas | 457
K. Spargias | 488
K.Raisakis | Aortic Valve Stenosis: Flow... 529
C.Naka | Aortic Valve Stenosis: When the... 483
L.Lakkas | A real-world case example 458
S.Karagiannis | Aortic Valve Stenosis: When... 421
K.Papadopoulos | A real-world case example... 428
P.Kourkoveli | A real-world case example... 467
Κωνσταντίνος Τσιούφης - Αναπληρωτής Καθηγητής... 548
K.Toutouzas | Patients with severe AS and... 428
I.Mastorakou | The imaging conundrum of... 459
Παναγιώτης Βάρδας - 7o Συνέδριο Διακαθετηριακής... 436
J.Velianou | Imaging guided differential... 500
Στρατής Παττακός - 7o Συνέδριο Διακαθετηριακής... 423
N.Pilatis | TAVR device selection for patients... 459
Γρηγόρης Παττακός - 7o Συνέδριο Διακαθετηριακής... 530
D.Tsikaderis | My best and worst TAVR case... 408
C.Arampatzis | My best and worst TAVR case... 433
V.Ninios | My best and worst Mitraclip case... 789
G.Siasos | My best and worst TAVR case of... 363
A.Ziakas | My best and worst TAVR case of... 382
R.Von Bardeleben | Impact of valvular heart... 436
M.Chrissoheris | PVL assessment and is paravalvular... 384
K.Spargias | Transcatheter “Edge-to-Edge”... 399
K.Toutouzas | Patients with severe AS and... 360
V.Bapat | Transcatheter Mitral valve Repair... 358
F.Faletra | Risk stratification in aortic... 386
D.Dvir | The spectrum of bioprostheticvalve... 332
C.Karvounis | The pathophysiology of functional... 348
M.Chrissoheris | Similarities and differences... 360
G.Makavos | Pacemaker-associated Tricuspid... 423
G.Pattakos | Surgical management of Tricuspid... 406
R.Von Bardeleben | Off-label, palliative... 432
K.Spargias | Tricuspid Technology: ViV,... 548
A.Tzifa | Transcatheter Pulmonary Valve... 469
James Velianou - 7th Conference of Transcatheter... 505
Michael Reardon - 7th Conference of Transcatheter... 416
Stephan Von Bardeleben - 3rd International... 364
105
Vinayak Bapat - 7th Conference of Transcatheter... 486
Στέλιος Κωνσταντινίδης - 7o Συνέδριο Διακαθετηριακής... 1.055
Γιώργος Ζαχαρόπουλος - 7o Συνέδριο Διακαθετηριακής... 434
Danny Dvir - 7th Conference of Transcatheter... 352
Χρίστος Ευτυχίου - 7o Συνέδριο Διακαθετηριακής... 1.421
M.Hamilos | The compelling saga of strokes... 374
K.Toutouzas | Comparison of the various... 428
M.Vavouranakis | TAVR Device Selection and... 459
D.Angouras | A Surgeon’s viewpoint on SAVR... 487
V.Lozos | TAVR alternative access: Transapical,... 409
M.Kasel | Transcaval TAVR for all who cannot... 406
T.Apostolopoulos | Incidence, predictors,... 514
A.Nikitopoulos | My best and worst TAVR... 508
D.Dvir | Management of bioprosthetic valve... 362
C.Eftychiou | Coronary Obstruction during... 1.146
J.Velianou | Importance of imaging in TAVR:... 408
M.Kasel | TAVR for non-calcific Aortic Insufficiency.... 348
G.Latsios | Prevention and management of... 698
D.Nikas | Optimal TAVR device placement... 423
D.Dvir | Techniques and outcomes of Trans-septal... 369
J.Kisslo | Fake news VS fact: Echo imaging... 314
M.Reardon | Low risk TAVR. What the future... 354
M.Reardon | Surgical and Transcatheter Mitral... 415
V.Bapat | Cardiothoracic surgeons and skills... 338
V.Bapat | TMVR today: Access routes and... 442
A.Colli | Transcatheter Mitral Valve chordal... 579
K.Spargias | My best and worst TMVR case... 587
K.Moldovan | TMVR in MAC: Lessons from the... 455
C.Kotoulas | TAVR 2018: The Landscape of... 383
G.Pavlides | TAVR 2018: Are the Guidelines... 448
P.Dardas | i. Pro 328
D.Angouras | ii. Con 322
E.Skalidis | iii. A real-world case example... 323
K.Spargias | i. Pro 322
A.Manolis | ii. Con 345
M.Drakopoulou | iii. A real-world case example... 333
G.Pattakos | The relationship between TAVR... 334
J.Velianou | The spectrum of bioprosthetic... 361
G.Dangas | The latest in TAVR adjunctive... 363
Κλείσιμο Συνεδρίου 412